Successful Management of Locally Advanced and Oligometastatic Urothelial Carcinoma with Pembrolizumab-based Induction Regimen Followed by Consolidative Radical Resection of the Primary Tumor: A Multi-institutional Case Series
07:30am
- 03:35pm
EDT
- April 6, 2024
Albert Jang, MD, Hematology and Medical Oncology Fellow, Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute